Product Information
DBPR112 is an analog that belongs to the group of kinase inhibitors. It has been shown to inhibit various kinases, which are enzymes involved in cellular signaling pathways that regulate cell growth and division. DBPR112 has demonstrated anticancer activity in vitro against a range of cancer cells, including Chinese hamster ovary cells, human breast cancer cells, and tumor xenografts. It also induces apoptosis, or programmed cell death, in cancer cells. DBPR112 is excreted in urine and may be used as a potential biomarker for monitoring anticancer therapy. This drug is not related to oseltamivir or any other antiviral medication but rather acts on protein targets within the cancer cell.
Chemical properties
Technical inquiry about: 3D-BZB54949 DBPR112
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
